| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
integrin subunit alpha 5 | 0.524 | 0.769 | 0.42 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2004 | 2005 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2014 | 2014 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
phenotype | 0.230 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2014 | ||||||||
|
neurotrophic receptor tyrosine kinase 1 | 0.422 | 0.808 | 2.0E-06 |
|
phenotype | 0.210 | None | 1.000 | 2 | 0 | 1998 | 2010 | ||||||||
|
adenosine kinase | 0.584 | 0.769 | 3.1E-04 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1999 | 2001 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
phenotype | 0.210 | None | 1.000 | 2 | 0 | 2007 | 2017 | ||||||||
|
microRNA 381 | 0.584 | 0.654 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
opioid related nociceptin receptor 1 | 0.628 | 0.462 | 0.48 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
pro-apoptotic WT1 regulator | 0.542 | 0.846 | 9.0E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 | 0.582 | 0.769 | 2.8E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
phenotype | 0.520 | None | 1.000 | 1 | 0 | 2007 | 2020 | ||||||||
|
prostaglandin E receptor 4 | 0.558 | 0.731 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
prostaglandin E receptor 3 | 0.601 | 0.731 | 0.37 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.600 | None | 1.000 | 1 | 0 | 2004 | 2020 | ||||||||
|
neuroligin 2 | 0.722 | 0.269 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
platelet activating factor receptor | 0.575 | 0.731 | 0.24 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
protein kinase C beta | 0.453 | 0.885 | 1.00 |
|
phenotype | 0.250 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
protein phosphatase 2 catalytic subunit alpha | 0.608 | 0.769 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
regulator of G protein signaling 4 | 0.621 | 0.577 | 5.1E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
bradykinin receptor B1 | 0.619 | 0.731 | 4.7E-03 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2003 | 2010 | ||||||||
|
neurotensin receptor 1 | 0.563 | 0.692 | 1.9E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
sodium voltage-gated channel alpha subunit 10 | 0.566 | 0.692 | 9.9E-38 |
|
phenotype | 0.620 | None | 1.000 | 1 | 0 | 2006 | 2017 |